Investment Committee Memo
Workflow
Step 1: Gather Inputs
Collect from the user (or from prior analysis in the session):
- Company overview and business description
- Industry/market context
- Historical financials (3-5 years)
- Management assessment
- Deal terms (price, structure, financing)
- Due diligence findings (commercial, financial, legal, operational)
- Value creation plan / 100-day plan
- Returns analysis (base, upside, downside)
Step 2: Draft Memo Structure
Standard CrowTech IC memo format:
I. Executive Summary (1 page)
- Company description, deal rationale, key terms
- Recommendation and headline returns
- Top 3 risks and mitigants
II. Company Overview (1-2 pages)
- Business description, products/services
- Customer/payor base and go-to-market
- Competitive positioning
- Management team
Example deal archetypes CrowTech targets (for reference when writing examples):
- Multi-state physician practice management platform (PPM) with $30M EBITDA, $250M EV
- Behavioral health outpatient roll-up, $8M EBITDA, $60M EV
- AI ambient scribe SaaS, $15M ARR, $80M EV
- ASC management platform, $20M EBITDA, $180M EV
- Home health regional operator, $10M EBITDA, $75M EV
- RCM automation platform, $25M ARR, $150M EV
III. Industry & Market (1 page)
- Market size and growth
- Competitive landscape (for healthcare services, reference comps such as USPH, SGRY, ADUS, LHCG, ENSG, ACHC, AMED, OPCH; for healthcare AI/tech-enabled, reference VEEV, HCAT, DOCS, HQY, EVH, PHR, RCM where relevant)
- Secular trends / tailwinds (e.g., site-of-service shift to ASC / home-based care, VBC adoption, aging demographics)
- Regulatory environment (CMS rulemaking, state CON, Stark/AKS, corporate practice of medicine; HIPAA / FDA pathway for clinical AI)
IV. Financial Analysis (2-3 pages)
- Historical performance (revenue, EBITDA, margins, cash flow)
- Quality of earnings adjustments; same-store vs. de novo vs. M&A decomposition for multi-site platforms
- Working capital analysis (including days in A/R, payor aging)
- Capex requirements (maintenance vs. de novo clinic build-out)
V. Investment Thesis (1 page)
- Why this is an attractive investment (3-5 pillars)
- Value creation levers (organic growth, margin expansion, M&A, multiple expansion, payor mix shift, VBC upside)
- 100-day priorities
VI. Deal Terms & Structure (1 page)
- Enterprise value and implied multiples
- Sources & uses
- Capital structure / leverage
- Key legal terms
VII. Returns Analysis (1 page)
- Base, upside, and downside scenarios
- IRR and MOIC across scenarios
- Key assumptions driving returns
- Sensitivity analysis
VIII. Risk Factors (1 page)
- Key risks ranked by severity and likelihood (reimbursement/rate cut exposure, payor concentration, clinical labor inflation, regulatory changes, key physician retention where applicable)
- Mitigants for each risk
- Deal-breaker risks (if any)
IX. Recommendation
- Clear recommendation: Proceed / Pass / Conditional proceed
- Key conditions or next steps
Step 3: Output Format
- Default: Word document (.docx) with professional formatting
- Alternative: Markdown for quick review
- Include tables for financials and returns, not just prose
Important Notes
- IC memos should be factual and balanced — present both bull and bear cases honestly
- Don't minimize risks. IC members will find them anyway; credibility matters
- Use CrowTech's standard memo template if the user provides one
- Financial tables should tie — check that EBITDA bridges, S&U balances, and returns math is consistent
- Ask for missing inputs rather than making assumptions on deal terms or returns